title: Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.
abstract: Glucosylceramide (GlcCer) is a major glycosphingolipid component of epidermis, which is thought to be related to the barrier function of skin permeability. However, the role of glycosphingolipids in keratinocyte growth and differentiation has not been fully clarified. It has been reported that D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), an inhibitor of GlcCer synthase (EC 2.4.1.80), depletes cells of glycosphingolipids. This inhibitor has been used as a tool for elucidating their functions. In the present study, the effect of PDMP on cultured normal human keratinocytes was investigated. The cells were treated with various concentrations of PDMP. Forty-eight hours later cell growth, thymidine incorporation, and lipid content were studied. The cell growth and the incorporation of thymidine into cells were inhibited by PDMP in a dose dependent manner. The synthesis of GlcCer was strongly inhibited by PDMP treatment, whereas no significant changes in ceramide level were observed. We concluded that GlcCer in epidermis may play an important role in regulating epidermal growth and suggested that PDMP may be beneficial for treating proliferative skin disorders in the future.
authors.affiliation: Department of Plastic Surgery, Kyorin University, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Takami
authors.forename: A
authors.initials: A
authors.lastname: Abe
authors.forename: T
authors.initials: T
authors.lastname: Matsuda
authors.forename: J A
authors.initials: JA
authors.lastname: Shayman
authors.forename: N S
authors.initials: NS
authors.lastname: Radin
authors.forename: R J
authors.initials: RJ
authors.lastname: Walter
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured / Q000187:drug effects / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors* / Q000187:drug effects; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects* / Q000473:pathology; D009025:Morpholines / Q000494:pharmacology*; D012016:Reference Values
chemical_list: D000970:Antineoplastic Agents; D009025:Morpholines; C033110:RV 538; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase